ATE19088T1 - Peptid und dessen verwendung. - Google Patents

Peptid und dessen verwendung.

Info

Publication number
ATE19088T1
ATE19088T1 AT83109402T AT83109402T ATE19088T1 AT E19088 T1 ATE19088 T1 AT E19088T1 AT 83109402 T AT83109402 T AT 83109402T AT 83109402 T AT83109402 T AT 83109402T AT E19088 T1 ATE19088 T1 AT E19088T1
Authority
AT
Austria
Prior art keywords
peptide
image
terminus
conjugate
acid residue
Prior art date
Application number
AT83109402T
Other languages
English (en)
Inventor
Kyozo Tsukamoto
Yuzo Ichimori
Mitsuhiro Wakimasu
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1982/000381 external-priority patent/WO1984001149A1/ja
Priority claimed from PCT/JP1982/000444 external-priority patent/WO1984002130A1/ja
Priority claimed from PCT/JP1983/000174 external-priority patent/WO1984004745A1/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE19088T1 publication Critical patent/ATE19088T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/861—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT83109402T 1982-09-22 1983-09-21 Peptid und dessen verwendung. ATE19088T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/JP1982/000381 WO1984001149A1 (en) 1982-09-22 1982-09-22 Novel polypeptide and its use
PCT/JP1982/000444 WO1984002130A1 (en) 1982-11-22 1982-11-22 Novel polypeptides and their use
PCT/JP1983/000174 WO1984004745A1 (en) 1983-05-31 1983-05-31 Novel polypeptides and their use
EP83109402A EP0103898B1 (de) 1982-09-22 1983-09-21 Peptid und dessen Verwendung

Publications (1)

Publication Number Publication Date
ATE19088T1 true ATE19088T1 (de) 1986-04-15

Family

ID=27303777

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83109402T ATE19088T1 (de) 1982-09-22 1983-09-21 Peptid und dessen verwendung.

Country Status (12)

Country Link
US (1) US4681848A (de)
EP (1) EP0103898B1 (de)
KR (1) KR910001726B1 (de)
AT (1) ATE19088T1 (de)
AU (1) AU564620B2 (de)
CA (1) CA1216807A (de)
DE (1) DE3362936D1 (de)
DK (1) DK430583A (de)
IE (1) IE56003B1 (de)
IL (1) IL69790A (de)
NZ (1) NZ205666A (de)
PH (1) PH22559A (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984002129A1 (en) * 1982-11-22 1984-06-07 Takeda Chemical Industries Ltd Human immune interferon protein and process for its preparation
US4599306A (en) * 1983-04-15 1986-07-08 Amgen Monoclonal antibodies which specifically bind to human immune interferon
US5030565A (en) * 1983-08-17 1991-07-09 Scripps Clinic And Research Foundation Polypeptide-induced monoclonal receptors to protein ligands
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
DK168016B1 (da) * 1983-12-26 1994-01-17 Kyowa Hakko Kogyo Kk Derivat af humant interferon-gamma-polypeptid
DE3414831A1 (de) * 1984-04-19 1985-10-31 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit human-gammainterferon-aktivitaet
IL75302A0 (en) * 1984-06-06 1985-09-29 Takeda Chemical Industries Ltd Novel polypeptide and production thereof
JPS6124599A (ja) * 1984-07-11 1986-02-03 Kyowa Hakko Kogyo Co Ltd 新規ヒトインタ−フエロン−ｒポリペプチド誘導体
NZ215967A (en) * 1985-05-01 1988-05-30 Commw Serum Lab Commission Composition of peptides of known weight for determining weight of unknown peptide
AU590754B2 (en) * 1985-05-01 1989-11-16 Commonwealth Serum Laboratories Commission Novel molecular weight standards and methods of use thereof
FR2584418B1 (fr) * 1985-07-05 1988-11-10 Unicet Laboratoires Anticorps monoclonaux contre le g-interferon, hybridomes produisant de tels anticorps, procede de preparation de tels anticorps et de tels hybridomes, leur utilisation pour differencier les gifs, et ensemble ou " kit " utilisant de tels anticorps
FR2600076A1 (fr) * 1986-06-12 1987-12-18 Fond Ctre Nal Transfusion Milieu de culture comportant de l'albumine humaine, procede de preparation d'un produit injectable a partir de ce milieu, produit obtenu et son utilisation, composition obtenue
US4798807A (en) * 1986-06-24 1989-01-17 The Regents Of The University Of California Monoclonal antibodies and method for detecting dioxins and dibenzofurans
CA1340698C (en) * 1986-07-25 1999-08-10 Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo Preparation and uses of interferon-gamma
US4851341A (en) * 1986-12-19 1989-07-25 Immunex Corporation Immunoaffinity purification system
IT1231727B (it) * 1989-08-11 1991-12-21 Enrico Savoldi Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone.
DE69115917T2 (de) * 1990-09-27 1996-05-23 Schering Corp Humane gammainterferonantagonisten
TW517067B (en) * 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
ATE307597T1 (de) * 1998-06-08 2005-11-15 Hoffmann La Roche Verwendung von peg-ifn-alpha und ribavirin zur behandlung chronischer hepatitis c
US6379903B1 (en) 1999-10-08 2002-04-30 Sigma-Aldrich Co. Purification of recombinant proteins fused to multiple epitopes
KR100936536B1 (ko) * 2003-01-18 2010-01-13 주식회사 바이오인프라 목표 부위 이외의 아민이 보호된 펩타이드, 그 제조방법및 이를 이용한 ｐｅｇ가 선택적으로 접합된 펩타이드의제조방법
CN105254537A (zh) * 2015-10-19 2016-01-20 上海吉尔多肽有限公司 一种Nα-芴甲氧羰基-谷氨酰胺叔丁酯的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364936A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human monocyte antigen and methods of preparing same
DE3200657A1 (de) * 1981-01-28 1983-02-17 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig Verfahren zur herstellung von einen antikoerper produzierenden hybridzellen und von antikoerpern, hybridzellen und antikoerper
US4473493A (en) * 1981-04-29 1984-09-25 Immunex Corporation Hybridoma antibody which inhibits interleukin 2 activity

Also Published As

Publication number Publication date
IE56003B1 (en) 1991-03-13
EP0103898A1 (de) 1984-03-28
IL69790A (en) 1986-08-31
CA1216807A (en) 1987-01-20
AU1934583A (en) 1984-03-29
DE3362936D1 (en) 1986-05-15
EP0103898B1 (de) 1986-04-09
DK430583D0 (da) 1983-09-21
KR840006329A (ko) 1984-11-29
DK430583A (da) 1984-03-23
NZ205666A (en) 1986-08-08
PH22559A (en) 1988-10-17
US4681848A (en) 1987-07-21
AU564620B2 (en) 1987-08-20
KR910001726B1 (ko) 1991-03-22
IE832215L (en) 1984-03-22

Similar Documents

Publication Publication Date Title
ATE19088T1 (de) Peptid und dessen verwendung.
EP0157643A2 (de) Antikörper zum menschlichen Interleukin-2, eingeführt durch synthetische Polypeptide
ATE98376T1 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
BG60256B1 (bg) Рекомбинантен метод за получаване на лимфотоксин
DK0737208T3 (da) Monoklonale antistoffer, der er specifikke for PHF-tau, hybridomaer, der secernerer dem, og antigen-genkendelse for disse antistoffer og deres anvendelsesmuligheder
SE9503925D0 (sv) Separationsmedium för IgG
FI954347A0 (fi) Monoklonaaliset vasta-ainekoostumukset ja monoklonaalisia vasta-aineita tuottavat hybridomat
DK60586A (da) Inhibin isoleret fra ovariefollikelvaeske og fremgangsmaade til isolering og rensning af inhibin
DE59209129D1 (de) Verwendung von Antikörper enthaltenden Präparationen zur Immunsuppression
RU94046414A (ru) Моноклональные антитела к гликопротеину р, их получение и применение, продуцирующие их клетки, иммунологический диагностический набор на их основе, терапевтический состав
FI925321A (fi) Immunodiagnostiskt ledinflammationstest
DK0418590T3 (da) Antistoffer, fremstilling deraf og anvendelse deraf
NO850087L (no) Bestemmelse av fibrin med fibrin-spesifikke antistoffer
ATE133993T1 (de) Protein-antikrebsmittel
EP0725081A4 (de) MONOKLONALER ANTIKÖRPER GEGEN MxA DES MENSCHLICHEN Mx PROTEINS
DE69311796D1 (de) Peptide von dem caseinomacropeptid, antikorper dagegen und ihre andwendungen
L'HARIDON et al. Production of an hybridoma library to recombinant porcine alpha I interferon: a very sensitive assay (ISBBA) allows the detection of a large number of clones
EP0502553A3 (en) Peptide fragment from human villin and antibody thereto
JPH0659231B2 (ja) 単一クローン抗体
Takeo et al. Studies on heterogeneity of anti-DNP antibody by means of two-dimensional affinity electrophoresis
JPS562947A (en) Peptide for analysis or parathyroid gland hormone
JPS5781448A (en) Human parathyroid hormone (1-38) fragment
CS276567B6 (en) Murine hybridoma ifna2-n7 producing a monoclonal antibody
CS277142B6 (en) Murine hybridoma ifna1-48 producing a monoclonal antibody